| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0043 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.0085 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0037 | 1 |